SALIX PHARMACEUTICALS LTD | 2013 | FY | 3


The following table summarizes information on the convertible debt at December 31 (in thousands):

 

     2013     2012  

Convertible Notes due 2028:

    

Principal amount of the liability component

   $ —       $ 12,500   

Unamortized discount

     —         (609
  

 

 

   

 

 

 

Net carrying amount

   $ —       $ 11,891   
  

 

 

   

 

 

 

Convertible Notes due 2015:

    

Principal amount of the liability component

   $ 345,000      $ 345,000   

Unamortized discount

     (26,356     (42,914
  

 

 

   

 

 

 

Net carrying amount

   $ 318,644      $ 302,086   
  

 

 

   

 

 

 

Convertible Notes due 2019:

    

Principal amount of the liability component

   $ 690,000      $ 690,000   

Unamortized discount

     (126,594     (146,768
  

 

 

   

 

 

 

Net carrying amount

   $ 563,406      $ 543,232   
  

 

 

   

 

 

 

Total Convertible Senior Notes

    

Principal amount of the liability component

   $ 1,035,000      $ 1,047,500   

Unamortized discount

     (152,950     (190,291
  

 

 

   

 

 

 

Net carrying amount

   $ 882,050      $ 857,209   
  

 

 

   

 

 

 

us-gaap:ScheduleOfDebtConversionsTextBlock